Literature DB >> 23763484

Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.

Enric Reverter1, Annabel Blasi, Juan G Abraldes, Graciela Martínez-Palli, Susana Seijo, Fanny Turon, Annalisa Berzigotti, Jaume Balust, Jaume Bosch, Juan C García-Pagán.   

Abstract

BACKGROUND & AIMS: Measurement of the hepatic venous pressure gradient (HVPG) offers valuable prognostic information in patients with cirrhosis. In specific circumstances, (children, agitated patients, TIPS placement) deep sedation is required. This study aims to assess the impact of deep sedation on the accuracy of hepatic/portal pressure measurements.
METHODS: Forty-four patients were included. Measurements of baseline HVPG (n = 30), HVPG response to i.v. propranolol (n = 11), portal pressure gradient (PPG) after TIPS (n = 27) and of cardio-pulmonary pressures (n = 25) were obtained in awake conditions and under deep sedation with propofol and remifentanil.
RESULTS: During deep sedation, a marked oscillation within respiratory cycle was observed in abdominal pressures. End-expiratory sedated HVPG showed a better agreement with awake HVPG (intra-class correlation coefficient - ICC 0.864) than end-inspiratory HVPG (ICC 0.796). However, in almost half of the patients both values differed by more than 10%. Accuracy was not improved by using mean HVPG along the respiratory cycle. Similarly, changes in HVPG caused by propranolol while under sedation had a poor agreement to those obtained in awake conditions. Indeed, about a half of patients were misclassified according to the 10% HVPG reduction target. After TIPS, PPG values obtained under sedation were significantly different to awake PPG, usually underestimating the awake value. The systemic hemodynamic changes induced by sedation were not associated to a greater variability of PPG/HVPG measurements.
CONCLUSION: Deep sedation with propofol and remifentanil adds substantial variability and uncertainty to HVPG/PPG measurements. This must be considered when using these values to estimate prognosis, or targeting HVPG/PPG reductions.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TIPS; anaesthesia; portal hypertension; propofol; remifentanil

Mesh:

Substances:

Year:  2013        PMID: 23763484     DOI: 10.1111/liv.12229

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Monitoring of systemic and hepatic hemodynamic parameters in mice.

Authors:  Chichi Xie; Weiwei Wei; Tao Zhang; Olaf Dirsch; Uta Dahmen
Journal:  J Vis Exp       Date:  2014-10-04       Impact factor: 1.355

Review 2.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

3.  The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis.

Authors:  Chuan Liu; Ruoyang Shao; Sining Wang; Guangchuan Wang; Lifen Wang; Mingyan Zhang; Yanna Liu; Mingkai Liang; Xiaoguo Li; Ning Kang; Jitao Wang; Dan Xu; Hua Mao; Chunqing Zhang; Xiaolong Qi
Journal:  Gastroenterol Res Pract       Date:  2020-11-24       Impact factor: 2.260

4.  Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population.

Authors:  Bertrand Le Roy; Emilie Grégoire; Cyril Cossé; Badr Serji; Nicolas Golse; René Adam; Daniel Cherqui; Jean-Yves Mabrut; Yves-Patrice Le Treut; Eric Vibert
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

5.  Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.

Authors:  Sara Santos; Eduardo Dantas; Filipe Veloso Gomes; José Hugo Luz; Nuno Vasco Costa; Tiago Bilhim; Filipe Calinas; Américo Martins; Élia Coimbra
Journal:  GE Port J Gastroenterol       Date:  2020-06-09

6.  Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week.

Authors:  Michael Bernhard Pitton; Arndt Weinmann; Roman Kloeckner; Jens Mittler; Christian Ruckes; Christoph Düber; Gerd Otto
Journal:  Cardiovasc Intervent Radiol       Date:  2021-12-01       Impact factor: 2.740

7.  Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.

Authors:  Fahim Ebrahimi; David Semela; Markus Heim
Journal:  Hepatol Int       Date:  2021-10-26       Impact factor: 9.029

8.  Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.

Authors:  Ipshita Gupta; John R Eisenbrey; Priscilla Machado; Maria Stanczak; Corinne E Wessner; Colette M Shaw; Sriharsha Gummadi; Jonathan M Fenkel; Alison Tan; Cynthia Miller; Julia Parent; Susan Schultz; Michael C Soulen; Chandra M Sehgal; Kirk Wallace; Flemming Forsberg
Journal:  Radiology       Date:  2020-11-17       Impact factor: 11.105

9.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Authors:  Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert
Journal:  Wien Klin Wochenschr       Date:  2017-10-23       Impact factor: 1.704

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.